|
|
||||||||
|
Interact CardioVasc Thorac Surg 2007;6:339. doi:10.1510/icvts.2006.141226A © 2007 European Association of Cardio-Thoracic Surgery
ICVTS on-line discussion A Minimizing CPB circuit and reducing use of homologous blood productsBakoulev Center for Cardiovascular Surgery, Moscow 121552, Russia eComment: Reduction of the CPB circuit and use of blood products in pediatric perfusion is possible by applying modern oxygenators, decreasing the length and diameter of tubing sets, avoiding arterial filter and optimal positioning of arterial pump with vacuum-assisted venous drainage [1, 2]. The residual volume may be processed by ultrafiltration and Cell-Saver [1]. In this article[3] the authors presented a decision of the given problem for perfusion in children with body weight <10 kg. Application of oxygenators Capiox Baby RX in the third group alone resulted in a reduction of twice the prime volume. At the same time, the usage of great amounts of RBC and FFP is noticed (303 and 251 ml respectively). That is aproximately equal to a child's circulatory blood volume in the group with a mean body weight of 5.3 kg. Compared to homologous hemotransfusion, the volume of cell savage product (56 ml) is meaningless. So the question arises of any medical or financial benefit in addition to using Cell-Saver. From our own experience, oxygenators Capiox Baby RX 0.5 provides short (<90 min) bloodless perfusion among children with body weight of 710 kg. For the last 4 years, more than 700 open heart procedures per year in children under 1 year of age have been performed at the Bakoulev Scientific Center for cardiovascular surgery. In the same group of patients, we usually use 2 types of oxygenators Lilliput-1 (prime volume 350 ml) and Lilliput-2 (prime volume 550600 ml). No additional modification of the CPB circuit, despite the maximal allowed shortening of tubing sets, were applied. An average amount of RBC administered during perfusion was 120150 ml and 200250 ml accordingly. During the postperfusional period we used the residual volume 1015 ml/kg with the control of ACT for the correction of hemodilution and circulating blood volume. We gave up using the residual volume in the rare cases of hemolysis in this group. Unfortunately, in those cases, there was no Cell-Saver. We apply MUF in newborns and infants with body weight <5 kg, who undergo complex procedures. MUF also allows the use of the residual volume maximal completely. At the end of CPB patients had Ht of 2830 % and by the end of surgical correction 3034%. Patients who underwent short perfusion usually did not need any additional RBC transfusions after CPB and during the first 24 h in ICU. Among natural colloids in this group, FFP was preferred. The average volume of FFP added during CPB was 150180 ml. During rewarming, routinely 10% albumin (3070 ml) was added. It was possible to use FFP after heparin neutralization by protamine (not more than 50 ml of FFP). The bloodless perfusion should be a preferable technique for most of the patients [4]. The prospective study by the authors will determine an optimal combination of the methods and so will more effectively reducing hemotransfusion in newborns and infants compared to presented results.
Related Article
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |